TIGIT and head and neck squamous cell carcinoma: It has been reported that circulating TIM-3+ TIGIT+ Tregs from HNSCC patients showed a high capacity for impeding T-cell proliferation by secreting granzime B and suppressive cytokines such as IL-10.